AAAAAA
Results:
1-9
|
Results: 9
Authors:
Matzku, S
Zoller, M
Citation: S. Matzku et M. Zoller, Specific immunotherapy of cancer in elderly patients, DRUG AGING, 18(9), 2001, pp. 639-664
Authors:
Christ, O
Matzku, S
Burger, C
Zoller, M
Citation: O. Christ et al., Interleukin 2-antibody and tumor necrosis factor-antibody fusion proteins induce different antitumor immune responses in vivo, CLIN CANC R, 7(5), 2001, pp. 1385-1397
Authors:
Christ, O
Seiter, S
Matzku, S
Burger, C
Zoller, M
Citation: O. Christ et al., Efficacy of local versus systemic application of antibody-cytokine fusion proteins in tumor therapy, CLIN CANC R, 7(4), 2001, pp. 985-998
Authors:
Wurfel, J
Seiter, S
Stassar, M
Claas, A
Klas, R
Rosel, M
Marhaba, R
Savelyeva, L
Schwab, M
Matzku, S
Zoller, M
Citation: J. Wurfel et al., Cloning of the human homologue of the metastasis-associated rat C4.4A, GENE, 262(1-2), 2001, pp. 35-41
Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy
Authors:
DeNardo, SJ
Burke, PA
Leigh, BR
O'Donnell, RT
Miers, LA
Kroger, LA
Goodman, SL
Matzku, S
Jonczyk, A
Lamborn, KR
DeNardo, GL
Citation: Sj. Denardo et al., Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy, CANC BIO R, 15(1), 2000, pp. 71-79
Authors:
Zoller, M
Matzku, S
Citation: M. Zoller et S. Matzku, Vaccination: A future modality of cancer therapy, DRUGS TODAY, 36(8), 2000, pp. 557-581
Authors:
Wild, MK
Strittmatter, W
Matzku, S
Schraven, B
Meuer, SC
Citation: Mk. Wild et al., Tumor therapy with bispecific antibody: The targeting and triggering stepscan be separated employing a CD2-based strategy (vol 163, pg 2064, 1999), J IMMUNOL, 164(10), 2000, pp. 5531-5531
Authors:
Zoller, M
Matzku, S
Citation: M. Zoller et S. Matzku, Cancer therapy: New concepts on active immunization, IMMUNOBIOL, 201(1), 1999, pp. 1-21
Authors:
Wild, MK
Strittmatter, W
Matzku, S
Schraven, B
Meuer, SC
Citation: Mk. Wild et al., Tumor therapy with bispecific antibody: The targeting and triggering stepscan be separated employing a CD2-based strategy, J IMMUNOL, 163(4), 1999, pp. 2064-2072
Risultati:
1-9
|